
New Data on HIV-1 Treatments, Including Biktarvy and Novel Lenacapavir Combination Regimen, Presented at CROI 2025
Presentations from Gilead Sciences at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 highlight advancements in potential treatments for HIV-1 infection, including positive long-term outcomes in patients with HIV and hepatitis B …